Target intelligence / Profile preview

Plasmodium falciparum heme detoxification system (PfHDS)

Target
PfHDS
Molecular classification
Enzyme, Protein complex, Metabolic pathway
01

Overview

The Plasmodium falciparum heme detoxification system is a critical survival mechanism located within the parasite's acidic digestive vacuole (Jolt et al., 2008). During the intraerythrocytic stage, the parasite ingests and degrades host hemoglobin to obtain essential amino acids, a process that releases large quantities of free heme (ferriprotoporphyrin IX). Because free heme is highly toxic, causing oxidative stress and membrane damage, the parasite utilizes a specialized machinery—including the Heme Detoxification Protein (HDP) and Histidine-Rich Proteins (HRP2/3)—to sequester and crystallize heme into insoluble, non-toxic hemozoin (Sullivan et al., 1996). This detoxification pathway is the primary target for several classes of antimalarial drugs, most notably the quinolines like chloroquine, which bind to heme and prevent its incorporation into hemozoin crystals (Combrinck et al., 2013). The resulting accumulation of free heme leads to parasite death through oxidative damage. The emergence of resistance, mediated by mutations in transporters like the P. falciparum chloroquine resistance transporter (PfCRT), remains a significant challenge in targeting this system (Fidock et al., 2000). Monitoring this target often involves detecting PfHRP2, which serves as a key diagnostic biomarker for P. falciparum infection.

Other names
Heme detoxification pathwayHemozoin formation complexHemoglobin degradation machineryPlasmodium falciparum heme and proximal parasite proteins in the food vacuole
02

Mechanism of action

Inhibition of the biocrystallization of toxic free heme into inert hemozoin crystals within the parasite's digestive vacuole (Sullivan et al., 1996; Combrinck et al., 2013).

03

Biological functions

Heme detoxificationHemoglobin catabolismIron homeostasis
04

Disease associations

MalariaInfection
05

Safety considerations

Drug resistance (pfcrt and pfmdr1 mutations)QT prolongationRetinopathyNeurotoxicity
06

Interacting drugs

Chloroquine

7 more in the full profile.

07

Biomarkers

Plasmodium falciparum histidine-rich protein 2 (PfHRP2)Hemozoin

Beyond the preview

Go deeper on Plasmodium falciparum heme detoxification system (PfHDS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum heme detoxification system (PfHDS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call